Loading stock…

National Health Investors, Inc. (NHI) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

National Health Investors, Inc.

NHIMarket cap $3.14BPrice $64.0

Country🇺🇸United States

SectorReal Estate

IndustryHealthcare REITs

Owns and leases senior housing, skilled nursing, and medical properties across the U.S., collecting rent from operators instead of running them. It's a landlord for America's aging population, betting on demographics no economy can slow down.

In Bastion Portfolios?

52W Return-13%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+11%7

Revenue Forecast

Rev CAGR (1y)+19%8

Rev CAGR (3y)+12%7

Rev CAGR (5y)+14%9

Earnings Forecast

EPS Growth Y+1-1%3

EPS Growth Y+2+9%6

EPS Growth Y+3+13%7

Quality

Margins

EBIT Margin46%10

Net Income Margin38%10

Free Cash Flow Margin57%10

Debt

Net Debt/EBITDA4.32

Efficiency

ROE11%5

ROA6%7

Earnings Stability44

GEAR+VERY STRONG87

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)223

P/E Ratio (Forward 3y)174

P/BV2.07

EV Multiples

EV/EBITDA Fwd154

EV/EBIT Fwd233

Yield

Free Cash Flow Yieldna–

Dividend Yield5.9%10

Momentum

Short term

1 month return-9%3

3 month return-15%2

YTD return-13%3

Mid term

Price vs 52wHigh73%4

1 year return-10%3

Long term

3 year return+45%5

5 year return+62%6

Risk Shield

Price Risk

Beta0.210

Volatility24%9

Free Cash Flow

Free Cash Flow Margin57%10

Free Cash Flow Yieldna–

Quality

ROCE8%4

Earnings Stability44

Net Debt/EBITDA4.32

02Growth

Is it actually growing, and how fast?

NHINational Health Investors

Revenue FY25$379M

GROWTH RATING↗

STRONG73 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+19%8

Revenue, next 3Y, CAGR+12%7

Revenue, next 5Y, CAGR+14%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-1%3

EPS growth, FY27E+9%6

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 73% of companies worldwide.

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 12%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 11%/yr over the last 3 years and is set to keep growing around 12%/yr.

The runway holds up: revenue is set to grow 14%/yr over five years.9/10

WATCH

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 12%/yr).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK21 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-15%2

YTD return-13%3

MID & LONG-TERM▾SCORE

% of 52-week high73%4

1-year return-10%3

3-year return+45%5

5-year return+62%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+45% over three years and +62% over five), roughly average for the market.

WEAKNESSES

It's down 10% over the past year, now 27% below its 52-week high. That is a touch behind the market.

The stock is underperforming over the past month (-9%), over three months (-15%) and so far this year (-13%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on National Health Investors, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

NHINational Health Investors

Revenue FY25$379M

GROWTH RATING↗

STRONG73 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+19%8

Revenue, next 3Y, CAGR+12%7

Revenue, next 5Y, CAGR+14%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-1%3

EPS growth, FY27E+9%6

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 73% of companies worldwide.

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 12%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 11%/yr over the last 3 years and is set to keep growing around 12%/yr.

The runway holds up: revenue is set to grow 14%/yr over five years.9/10

WATCH

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 12%/yr).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK21 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-15%2

YTD return-13%3

MID & LONG-TERM▾SCORE

% of 52-week high73%4

1-year return-10%3

3-year return+45%5

5-year return+62%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+45% over three years and +62% over five), roughly average for the market.

WEAKNESSES

It's down 10% over the past year, now 27% below its 52-week high. That is a touch behind the market.

The stock is underperforming over the past month (-9%), over three months (-15%) and so far this year (-13%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on National Health Investors, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community